-
-
-
-
-
-
-
Omeros (OMER) Halted on Circuit Volatility, Down 22%
-
-
-
-
-
-
-
Omeros reschedules YARTEMLEA approval conference call to January 7
-
-
-
-
-
-
-
Omeros Corp. (OMER) PT Raised to $20 at H.C. Wainwright
-
-
-
-
-
-
-
Omeros (OMER) Reports Q1 Loss of $0.58
-
-
-
-
-
-
-
Omeros (OMER) Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint
-
-
-
-
-
-
-
Rodman & Renshaw Starts Omeros Corp. (OMER) at Buy
-
-
428,392 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

